Literature DB >> 2247934

DNA restriction endonuclease cleavage pattern and protein antigen profile of Ehrlichia risticii.

S K Dutta1, B Shankarappa, S R Thaker, B L Mattingly-Napier.   

Abstract

Molecular characterization of Ehrlichia risticii, the etiological agent of Potomac horse fever, was performed. Restriction endonuclease cleavage of E. risticii DNA generated distinct patterns by different enzymes. The DNA cleavage patterns of E. risticii isolates obtained from different geographic regions were similar. Protein analysis identified thirty-five distinct proteins with molecular weights ranging from 160 to 16 kilodalton (kDa). Antigenic analysis by radioimmunoprecipitation using 125I surface labeled E. risticii and by Western blotting determined the presence of eighteen antigens (160, 110, 86, 84, 81, 70, 55, 51, 49, 44, 41, 36, 33, 31, 28, 24, 22 and 16 kDa) of which nine (110, 86, 70, 55, 51, 49, 44, 33, and 28 kDa) were major antigens. Fourteen of these antigens, which included the major antigens, were apparent surface components. There were no heat-modifiable proteins but lipopolysaccharide components of 245 and 14 kDa, resistant to proteinase K and of non-antigenic character, were detected in the organism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2247934     DOI: 10.1016/0378-1135(90)90090-i

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  10 in total

1.  Association of deficiency in antibody response to vaccine and heterogeneity of Ehrlichia risticii strains with Potomac horse fever vaccine failure in horses.

Authors:  S K Dutta; R Vemulapalli; B Biswas
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

2.  Production and characterization of Ehrlichia risticii, the agent of Potomac horse fever, from snails (Pleuroceridae: Juga spp.) in aquarium culture and genetic comparison to equine strains.

Authors:  G H Reubel; J E Barlough; J E Madigan
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Analysis of complete genome sequence of Neorickettsia risticii: causative agent of Potomac horse fever.

Authors:  Mingqun Lin; Chunbin Zhang; Kathryn Gibson; Yasuko Rikihisa
Journal:  Nucleic Acids Res       Date:  2009-08-06       Impact factor: 16.971

4.  Diagnostic application of polymerase chain reaction for detection of Ehrlichia risticii in equine monocytic ehrlichiosis (Potomac horse fever).

Authors:  B Biswas; D Mukherjee; B L Mattingly-Napier; S K Dutta
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Detection of Ehrlichia risticii, the agent of Potomac horse fever, in freshwater stream snails (Pleuroceridae: Juga spp.) from northern California.

Authors:  J E Barlough; G H Reubel; J E Madigan; L K Vredevoe; P E Miller; Y Rikihisa
Journal:  Appl Environ Microbiol       Date:  1998-08       Impact factor: 4.792

6.  Pathogenic, immunologic, and molecular differences between two Ehrlichia risticii strains.

Authors:  R Vemulapalli; B Biswas; S K Dutta
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  Identification of the protective 44-kilodalton recombinant antigen of Ehrlichia risticii.

Authors:  B Shankarappa; S K Dutta; B Mattingly-Napier
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Antigenic, morphologic, and molecular characterization of new Ehrlichia risticii isolates.

Authors:  W Chaichanasiriwithaya; Y Rikihisa; S Yamamoto; S Reed; T B Crawford; L E Perryman; G H Palmer
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

9.  Molecular basis for antigenic variation of a protective strain-specific antigen of Ehrlichia risticii.

Authors:  B Biswas; R Vemulapalli; S K Dutta
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Molecular cloning and analysis of recombinant major antigens of Ehrlichia risticii.

Authors:  S K Dutta; B Shankarappa; B L Mattingly-Napier
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.